Maintain BUY with a revised TP of Rs. 260 (Rs. 215 earlier) as we revise our FY21/22E estimate and roll over to FY23E numbers. However, undemanding valuations, +5% dividend yield and visible recovery across key businesses makes it an attractive bet.